A metabolic perspective on eIF1A and eIF3B inhibition as a potential therapeutic strategy in psoriasis
Natalie Bordag, Benjamin M. R. Bourgeois, Tobias Madl, Peter Wolf, Nicole Golob‐Schwarzl
This study investigates the metabolic effects of eIF1A and eIF3B inhibition in psoriasis models, finding context-dependent metabolic changes and therapeutic benefits.
bioRxiv · Oct 15, 2026 · PreprintMolecular Biology